Reshma KewalramaniFiled
CEO & PresidentExecutiveDirectorCIK 1735944
- VRTXVERTEX PHARMACEUTICALS INC / MACEO & Presidentfiled Mar 3, 2026
Net · 12 months
-$19.7M
Open-market buys − sales
Sold · 12 months
$19.7M
$0 in 90d · 18 sales on record
Bought · 12 months
$0
$0 in 90d · 2 buys on record
Under 10b5-1
100%
Share of sale value under a trading plan
Last trade
Feb 27, 2026
Filed Mar 3, 2026 · 43 rows
Monthly open-market value · 24 months Filed
- Bought (open market)
- Sold (open market)
Unusual activity Estimated
Whale score 88Whale watch
- 65Insider overlapPublic Jul 21, 2026 · traded Mar 27, 2026
Sen. Alan Armstrong bought VRTX 28 days after its CEO sold $7.7M
Details
- Politician
- Alan Armstrong
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock
- Tx type
- buy
- Traded
- Mar 27, 2026
- Filed
- Jul 21, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 116
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true,"filing_date":"2026-03-03"}
- Days between
- 28
- Opposite side
- Yes
- Public from
- Jul 21, 2026
- Method version
- 2026-11-03
- 65Insider overlapPublic Apr 7, 2026 · traded Mar 23, 2026
Rep. Ro Khanna's spouse bought VRTX 24 days after its CEO sold $7.7M
Details
- Politician
- Ro Khanna
- Ticker
- VRTX
- Asset
- VERTEX PHARMACEUTICALS INCORPO CMN
- Tx type
- buy
- Traded
- Mar 23, 2026
- Filed
- Apr 7, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 15
- Owner type
- spouse
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true,"filing_date":"2026-03-03"}
- Days between
- 24
- Opposite side
- Yes
- Public from
- Apr 7, 2026
- Method version
- 2026-11-03
- 50Insider overlapPublic Mar 3, 2026 · traded Jan 29, 2026
Rep. David J. Taylor sold VRTX 29 days before its CEO sold $7.7M
Details
- Politician
- David J. Taylor
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- sell
- Traded
- Jan 29, 2026
- Filed
- Feb 2, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 4
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true,"filing_date":"2026-03-03"}
- Days between
- -29
- Opposite side
- No
- Public from
- Mar 3, 2026
- Method version
- 2026-11-03
- 28Exec salePublic Mar 3, 2026 · traded Feb 27, 2026
VRTX CEO Reshma Kewalramani sold $7.7M (10b5-1 plan)
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Traded
- Feb 27, 2026
- Shares
- 15,580
- Price
- $495
- Value
- $7.7M
- Is 10b5 1
- Yes
- Filed
- Mar 3, 2026
- Public from
- Mar 3, 2026
- Method version
- 2026-11-03
- 65Insider overlapPublic Jan 13, 2026 · traded Oct 23, 2024
Rep. Julia Letlow bought VRTX 16 days before its CEO sold $7.8M
Details
- Politician
- Julia Letlow
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- buy
- Traded
- Oct 23, 2024
- Filed
- Jan 13, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 447
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2024-11-08","shares":15198,"price":515,"value":7826970,"is_10b5_1":true,"filing_date":"2024-11-12"}
- Days between
- -16
- Opposite side
- Yes
- Public from
- Jan 13, 2026
- Method version
- 2026-11-03
- 65Insider overlapPublic Oct 3, 2025 · traded Sep 5, 2025
Rep. Ro Khanna's spouse partially sold VRTX 30 days after its CEO bought $2.2M
Details
- Politician
- Ro Khanna
- Ticker
- VRTX
- Asset
- VERTEX PHARMACEUTICALS INCORPO CMN
- Tx type
- partial_sale
- Traded
- Sep 5, 2025
- Filed
- Oct 3, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 28
- Owner type
- spouse
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_buy","tx_date":"2025-08-06","shares":5710,"price":389.95,"value":2226614.5,"is_10b5_1":false,"filing_date":"2025-08-07"}
- Days between
- 30
- Opposite side
- Yes
- Public from
- Oct 3, 2025
- Method version
- 2026-11-03
- 50Insider overlapPublic Sep 9, 2025 · traded Aug 4, 2025
Rep. Ro Khanna's spouse bought VRTX 2 days before its CEO bought $2.2M
Details
- Politician
- Ro Khanna
- Ticker
- VRTX
- Asset
- VERTEX PHARMACEUTICALS INCORPO
- Tx type
- buy
- Traded
- Aug 4, 2025
- Filed
- Sep 9, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 36
- Owner type
- spouse
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_buy","tx_date":"2025-08-06","shares":5710,"price":389.95,"value":2226614.5,"is_10b5_1":false,"filing_date":"2025-08-07"}
- Days between
- -2
- Opposite side
- No
- Public from
- Sep 9, 2025
- Method version
- 2026-11-03
- 50Insider overlapPublic Sep 2, 2025 · traded Aug 7, 2025
Rep. David J. Taylor bought VRTX 1 day after its CEO bought $2.2M
Details
- Politician
- David J. Taylor
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- buy
- Traded
- Aug 7, 2025
- Filed
- Sep 2, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 26
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_buy","tx_date":"2025-08-06","shares":5710,"price":389.95,"value":2226614.5,"is_10b5_1":false,"filing_date":"2025-08-07"}
- Days between
- 1
- Opposite side
- No
- Public from
- Sep 2, 2025
- Method version
- 2026-11-03
- 65Exec buyPublic Aug 7, 2025 · traded Aug 6, 2025
VRTX CEO Reshma Kewalramani bought $2.2M on the open market
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_buy
- Traded
- Aug 6, 2025
- Shares
- 5,710
- Price
- $390
- Value
- $2.2M
- Is 10b5 1
- No
- Filed
- Aug 7, 2025
- Public from
- Aug 7, 2025
- Method version
- 2026-11-03
- 63Exec buyPublic Aug 7, 2025 · traded Aug 6, 2025
VRTX CEO Reshma Kewalramani bought $1.7M on the open market
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_buy
- Traded
- Aug 6, 2025
- Shares
- 4,290
- Price
- $389
- Value
- $1.7M
- Is 10b5 1
- No
- Filed
- Aug 7, 2025
- Public from
- Aug 7, 2025
- Method version
- 2026-11-03
Transactions
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice. Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4; the whale score is a model ranking of that filed activity.